X4 Pharmaceuticals

XFOR

Börsenwert 340 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	12,4 Mio. $	–	–	–
2	2 NEA Management Company Timonium, Maryland	11 Mio. $	–	–	–
3	3 BlackRock New York	8,11 Mio. $	-79.720 $	-5.001	-1 %
4	4 Vanguard Group Malvern, Pennsylvania	6,02 Mio. $	-127.447 $	-7.995	-3 %
5	ACA 5 Acorn Capital Advisors New York	5,36 Mio. $	+3,88 Mio. $	+243.688	Neu
6	6 OrbiMed New York	5,23 Mio. $	–	–	–
7	KCM 7 Kingdon Capital Management New York	3,62 Mio. $	+158.515 $	+9.944	+6 %
8	8 Geode Capital Management Boston, Massachusetts	2,57 Mio. $	+26.414 $	+1.657	+1 %
9	9 Axa Paris, France	2,25 Mio. $	-2.551 $	-160	-0,2 %
10	10 State Street Boston, Massachusetts	2,24 Mio. $	+55.474 $	+3.480	+4 %
11	11 Ensign Peak Advisors Salt Lake City, Utah	1,87 Mio. $	–	–	–
12	12 Susquehanna International Group Bala Cynwyd, Pennsylvania	1,38 Mio. $	+911.176 $	+57.160	+992 %
13	13 Pale Fire Capital SE Prague, Czech Republic	1,03 Mio. $	-106.708 $	-6.694	-13 %
14	14 Schonfeld Strategic Advisors New York	1,02 Mio. $	-280.542 $	-17.599	-27 %
15	15 Northern Trust Chicago, Illinois	995.891 $	+20.149 $	+1.264	+3 %
16	16 GSA Capital Partners London, United Kingdom	934.000 $	+407.001 $	+25.532	+151 %
17	17 UBS O'Connor Chicago, Illinois	928.039 $	-151.438 $	-9.500	-18 %
18	18 UBS Group Zurich, Switzerland	677.526 $	+351.734 $	+22.065	+254 %
19	19 Group One Trading Chicago, Illinois	584.981 $	+357.026 $	+22.397	+535 %
20	20 Point72 Asset Management Stamford, Connecticut	476.840 $	+13.263 $	+832	+4 %
21	21 Jane Street New York	428.043 $	+178.011 $	+11.167	+135 %
22	22 Morgan Stanley New York	403.844 $	+31.802 $	+1.995	+12 %
23	23 Goldman Sachs New York	350.395 $	+98.323 $	+6.168	+63 %
24	24 JP Morgan Chase New York	337.202 $	+203.612 $	+12.773	+501 %
25	25 Charles Schwab San Francisco, California	321.469 $	–	–	–

X4 Pharmaceuticals XFOR Börsenwert 340 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 340 Mio. $